PowerUp Acquisition (PWUP) Competitors $0.54 -0.04 (-7.00%) As of 09/4/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock PWUP vs. EDSA, LSB, CYCC, HOTH, BLRX, CMMB, LPCN, MRKR, ADAP, and ATHAShould you be buying PowerUp Acquisition stock or one of its competitors? The main competitors of PowerUp Acquisition include Edesa Biotech (EDSA), LakeShore Biopharma (LSB), Cyclacel Pharmaceuticals (CYCC), Hoth Therapeutics (HOTH), BioLineRx (BLRX), Chemomab Therapeutics (CMMB), Lipocine (LPCN), Marker Therapeutics (MRKR), Adaptimmune Therapeutics (ADAP), and Athira Pharma (ATHA). These companies are all part of the "pharmaceutical products" industry. PowerUp Acquisition vs. Its Competitors Edesa Biotech LakeShore Biopharma Cyclacel Pharmaceuticals Hoth Therapeutics BioLineRx Chemomab Therapeutics Lipocine Marker Therapeutics Adaptimmune Therapeutics Athira Pharma Edesa Biotech (NASDAQ:EDSA) and PowerUp Acquisition (NASDAQ:PWUP) are both small-cap pharmaceutical products companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, media sentiment, valuation, profitability and analyst recommendations. Which has stronger earnings & valuation, EDSA or PWUP? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdesa BiotechN/AN/A-$6.17M-$1.32-1.89PowerUp AcquisitionN/AN/AN/AN/AN/A Does the media refer more to EDSA or PWUP? In the previous week, Edesa Biotech's average media sentiment score of 0.00 equaled PowerUp Acquisition'saverage media sentiment score. Company Overall Sentiment Edesa Biotech Neutral PowerUp Acquisition Neutral Do insiders and institutionals believe in EDSA or PWUP? 5.5% of Edesa Biotech shares are held by institutional investors. Comparatively, 19.2% of PowerUp Acquisition shares are held by institutional investors. 22.6% of Edesa Biotech shares are held by insiders. Comparatively, 48.0% of PowerUp Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is EDSA or PWUP more profitable? PowerUp Acquisition's return on equity of 0.00% beat Edesa Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Edesa BiotechN/A -162.95% -60.33% PowerUp Acquisition N/A N/A N/A Do analysts prefer EDSA or PWUP? Edesa Biotech presently has a consensus target price of $5.00, indicating a potential upside of 100.48%. Given Edesa Biotech's stronger consensus rating and higher probable upside, equities analysts clearly believe Edesa Biotech is more favorable than PowerUp Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edesa Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 4.00PowerUp Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk & volatility, EDSA or PWUP? Edesa Biotech has a beta of 0.1, suggesting that its share price is 90% less volatile than the S&P 500. Comparatively, PowerUp Acquisition has a beta of 0.05, suggesting that its share price is 95% less volatile than the S&P 500. SummaryEdesa Biotech and PowerUp Acquisition tied by winning 4 of the 8 factors compared between the two stocks. Get PowerUp Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for PWUP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PWUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PWUP vs. The Competition Export to ExcelMetricPowerUp AcquisitionHolding Offices IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$4.23M$217.99M$2.52B$9.92BDividend YieldN/A3.17%2.54%4.52%P/E RatioN/A0.1726.4026.67Price / SalesN/A435.69109.33206.13Price / CashN/A123.7023.2658.92Price / BookN/A7.0331.406.09Net IncomeN/A-$11.59M$16.40M$266.14M7 Day Performance-2.12%-2.52%0.45%0.22%1 Month Performance49.42%2.40%3.16%4.08%1 Year Performance-95.15%164.34%33.95%23.89% PowerUp Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PWUPPowerUp AcquisitionN/A$0.54-7.0%N/A-94.8%$4.23MN/A0.00N/AGap DownHigh Trading VolumeEDSAEdesa Biotech1.2448 of 5 stars$2.44+0.6%$5.00+105.3%-41.3%$17.03MN/A-1.8420Gap UpLSBLakeShore Biopharma1.6433 of 5 stars$0.81-0.9%N/A-82.1%$17.03M$85.67M0.00773Positive NewsShort Interest ↓Gap DownCYCCCyclacel Pharmaceuticals1.4076 of 5 stars$7.49-0.8%N/A-97.1%$16.90M$40K-0.0114Positive NewsShort Interest ↓HOTHHoth Therapeutics2.6192 of 5 stars$1.23-1.6%$4.00+225.2%+88.8%$16.57MN/A-1.154BLRXBioLineRx2.3725 of 5 stars$3.61-6.2%$26.00+620.2%-85.8%$16.41M$17.25M-0.4140High Trading VolumeCMMBChemomab Therapeutics3.3439 of 5 stars$3.40-2.3%$8.50+150.0%-68.5%$16.40MN/A-5.7620News CoverageShort Interest ↓LPCNLipocine2.7516 of 5 stars$3.08+1.8%$9.00+192.7%-22.3%$16.37M$11.20M-3.5310Gap DownMRKRMarker Therapeutics4.1812 of 5 stars$1.00-20.6%$13.17+1,216.7%-72.1%$16.30M$6.59M-0.7360Short Interest ↓High Trading VolumeADAPAdaptimmune Therapeutics2.1446 of 5 stars$0.06-4.9%$1.35+2,230.5%-95.6%$16.17M$178.03M-0.09490Negative NewsShort Interest ↑Gap UpATHAAthira Pharma3.5687 of 5 stars$0.41-1.2%$0.50+23.5%-36.6%$16.17MN/A-0.2640 Related Companies and Tools Related Companies EDSA Competitors LSB Competitors CYCC Competitors HOTH Competitors BLRX Competitors CMMB Competitors LPCN Competitors MRKR Competitors ADAP Competitors ATHA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PWUP) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PowerUp Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share PowerUp Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
